Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment

被引：32

作者：

Bonora, Stefano ^{[1
]}

Lanzarfarne, Massimiliano ^{[2
]}

D'Avolio, Antonio ^{[1
]}

Trentini, Laura ^{[1
,2
]}

Lattuada, Emanuela ^{[2
]}

Concia, Ercole

Di Perri, Giovanni ^{[1
]}

机构：

[1] Univ Verona, GB Rossi Hosp, Dept Infect Dis, I-37100 Verona, Italy

[2] Univ Verona, GB Rossi Hosp, Infect Dis Unit, I-37100 Verona, Italy

来源：

CLINICAL INFECTIOUS DISEASES | 2008年 / 46卷 / 01期

关键词：

D O I：

10.1086/524086

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：146 / 147

页数：2

共 7 条

[1] Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations [J].

Barry, M ;

Gibbons, S ;

Back, D ;

Mulcahy, F .

CLINICAL PHARMACOKINETICS, 1997, 32 (03) :194-209

[2] Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms [J].

Dentali, F. ;

Ageno, W. ;

Crowther, M. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) :1853-1863

[3] Need for increased dose of warfarin in HIV patients taking nevirapine [J].

Dionisio, D ;

Mininni, S ;

Bartolozzi, D ;

Esperti, F ;

Vivarelli, A ;

Leoncini, F .

AIDS, 2001, 15 (02) :277-278

[4] A potentially significant interaction between efavirenz and phenytoin: A case report and review of the literature [J].

Robertson, SM ;

Penzak, SR ;

Lane, J ;

Pau, AK ;

Mican, JM .

CLINICAL INFECTIOUS DISEASES, 2005, 41 (02) :E15-E18

[5] Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors [J].

Smith, PF ;

DiCenzo, R ;

Morse, GD .

CLINICAL PHARMACOKINETICS, 2001, 40 (12) :893-905

[6] Comparative pharmacokinetics of vitamin K antagonists - Warfarin, phenprocoumon and acenocoumarol [J].

Ufer, M .

CLINICAL PHARMACOKINETICS, 2005, 44 (12) :1227-1246

[7]

YEH R, 2004, PROGR ABSTR 5 INT WO, V10

← 1 →